DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 778 filers reported holding DANAHER CORPORATION in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $25,754,000 | +33.3% | 327,112 | +27.0% | 5.88% | +5.4% |
| Q1 2014 | $19,322,000 | -2.7% | 257,627 | +0.1% | 5.58% | +1.5% |
| Q4 2013 | $19,862,000 | +12.2% | 257,275 | +0.8% | 5.50% | +5.3% |
| Q3 2013 | $17,695,000 | +9.9% | 255,259 | +0.4% | 5.22% | +7.9% |
| Q2 2013 | $16,095,000 | -23.2% | 254,258 | -33.1% | 4.84% | +16.9% |
| Q3 2012 | $20,947,000 | +22.7% | 379,814 | +15.8% | 4.14% | +11.1% |
| Q2 2012 | $17,076,000 | -7.1% | 327,878 | -0.1% | 3.72% | +1.8% |
| Q1 2012 | $18,376,000 | +108.7% | 328,143 | +75.3% | 3.66% | +4.5% |
| Q4 2011 | $8,805,000 | +9.0% | 187,186 | -2.8% | 3.50% | +0.6% |
| Q3 2011 | $8,077,000 | -13.7% | 192,592 | +9.1% | 3.48% | -3.2% |
| Q2 2011 | $9,360,000 | +110.7% | 176,592 | +106.3% | 3.59% | +40.2% |
| Q1 2011 | $4,443,000 | +42.7% | 85,592 | +29.7% | 2.56% | +10.6% |
| Q4 2010 | $3,113,000 | – | 65,992 | – | 2.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |